Home Cart Sign in  
Chemical Structure| 213261-59-7 Chemical Structure| 213261-59-7

Structure of RITA
CAS No.: 213261-59-7

Chemical Structure| 213261-59-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

RITA induced both DNA-protein and DNA-DNA cross-links with no detectable DNA single-strand breaks. It is MDM2-p53 interaction inhibitor and activates p53 expression.

Synonyms: NSC 652287; 2,5-bis(5-hydroxymethyl-2-thienyl) Furan; Reactivation of p53 and Induction of Tumor Cell Apoptosis

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of RITA

CAS No. :213261-59-7
Formula : C14H12O3S2
M.W : 292.37
SMILES Code : OCC1=CC=C(C2=CC=C(C3=CC=C(CO)S3)O2)S1
Synonyms :
NSC 652287; 2,5-bis(5-hydroxymethyl-2-thienyl) Furan; Reactivation of p53 and Induction of Tumor Cell Apoptosis
MDL No. :MFCD03235294
InChI Key :KZENBFUSKMWCJF-UHFFFAOYSA-N
Pubchem ID :374536

Safety of RITA

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of RITA

DNA

Isoform Comparison

Biological Activity

Target
  • E3 Ligase

In Vitro:

Cell Line
Concentration Treated Time Description References
NHDF 1 μM 8 hours In untransformed cells, RITA treatment did not affect HdmX protein levels. PMC3190111
MCF10A 1 μM 8 hours In untransformed cells, RITA treatment did not affect HdmX protein levels. PMC3190111
Saos-2 1 μM 8 hours In p53-null cells, RITA treatment did not affect HdmX protein levels. PMC3190111
H1299 1 μM 8 hours In p53-null cells, RITA treatment did not affect HdmX protein levels. PMC3190111
HCT116 cells 1.0 μM 24 hours To study the effects of RITA on cell cycle and apoptosis PMC3354051
Mel202 cells 0.25 μM 24 hours To study RITA-induced Chk2 phosphorylation and its role in apoptosis PMC3354051
184A1 1 μM 8 hours In untransformed cells, RITA treatment did not affect HdmX protein levels. PMC3190111
Saos-2 500 nM 16 h No significant apoptotic or DNA damage response observed PMC3122121
HCT116 p53-/- 500 nM 16 h No significant apoptotic or DNA damage response observed PMC3122121
HCT116 p53+/+ 500 nM 16 h Induces p53-dependent apoptosis and DNA damage response PMC3122121
P53-/- HCT116 cells 1 μM 16 hours RITA did not affect HIF-1α levels. PMC2663300
P53+/+ HCT116 cells 1 μM 16 hours RITA blocked HIF-1α induction in hypoxia and significantly inhibited VEGF expression. PMC2663300
MDA-MB-231 cells 1 μM 16 hours RITA did not induce p53 expression or affect HIF-1α levels. PMC2663300
MCF-7 cells 1 μM 16 hours RITA induced p53 expression in both normoxia and hypoxia and blocked hypoxia-induced HIF-1α accumulation. PMC2663300
MCF-7 1 µM 20 min Induces DNA damage PMC3122121
MCF10A-HRASV12 cells 1 μM 24 hours To assess the role of Pin1 in RITA-induced apoptosis in RAS-transformed cells, results showed that Pin1 expression levels are a key determinant of cancer cell sensitivity to RITA. PMC3554345
HCT116 p53+/+ cells 1 μM 24 hours To study RITA-induced mitochondrial accumulation of p53 and transcription-independent apoptosis, results showed that RITA treatment caused accumulation of endogenous p53 in the mitochondrial fraction. PMC3554345
OVCAR4 1 μM 48 hours Induction of cell death PMC4123078
OVCAR3 1 μM 48 hours Induction of cell death PMC4123078
OVCAR5 1 μM 48 hours Induction of cell death PMC4123078
H460 1 μM 48 hours Induction of cell death PMC4123078
NTERA-2D1 1 μM 48 hours Induction of cell death PMC4123078
HN4-ritaR 5 μM 72 hours RITA failed to significantly induce apoptosis in HN4-ritaR cells, with sustained autophagy-related protein expression PMC5925444
HN4-cisR 5 μM 72 hours RITA failed to significantly induce apoptosis in HN4-cisR cells, with sustained autophagy-related protein expression PMC5925444
AMC-HN7 5 μM 72 hours RITA failed to significantly induce apoptosis in AMC-HN7 cells, with sustained or increased autophagy-related protein expression PMC5925444
AMC-HN6 5 μM 72 hours RITA failed to significantly induce apoptosis in AMC-HN6 cells, with sustained or increased autophagy-related protein expression PMC5925444
HCT116 TP53-/- 1 μM 8 hours In p53-null cells, RITA treatment did not affect HdmX protein levels. PMC3190111
AMC-HN9 5 μM 72 hours RITA induced apoptosis in AMC-HN9 cells and decreased autophagy-related protein expression PMC5925444
AMC-HN4 5 μM 72 hours RITA induced apoptosis in AMC-HN4 cells and decreased autophagy-related protein expression PMC5925444
RKO ARID1AOE 129.7 μM and 73.4 μM (IC50) 72 hours Evaluate the inhibitory effect of RITA on RKO ARID1A-overexpressing cells PMC11136964
RKO ARID1A−/− 18.2 μM (IC50) 72 hours Evaluate the inhibitory effect of RITA on RKO ARID1A-deficient cells PMC11136964
HCT116 ARID1A−/− 2.0 μM and 3.4 μM (IC50) 72 hours Evaluate the inhibitory effect of RITA on ARID1A-deficient cells PMC11136964
HCT116 ARID1A+/+ 16.7 μM (IC50) 72 hours Evaluate the inhibitory effect of RITA on ARID1A wild-type cells PMC11136964
HCT116 cells 1 μM 8 hours RITA treatment promotes the formation of covalently linked TrxR1 oligomers, correlating with cell death PMC4669772
MCF7 cells 1 μM 8 hours Analysis of p53 genomic occupancy and gene expression to identify novel p53 target genes PMC3504713
MCF7 1 μM 8 hours RITA treatment led to a decrease in HdmX protein levels, while nutlin3a or DMSO control treatment had no such effect. PMC3190111
HCT116 1 μM 8 hours RITA treatment led to a decrease in HdmX protein levels, while nutlin3a or DMSO control treatment had no such effect. PMC3190111
UKF-NB-3rRITA10μM cells 10 μM To study the effects of RITA on p53 activation and apoptosis, results showed RITA induced p53 activation and apoptosis PMC3358013
H460 0.25 μM Evaluate the antiproliferative activity of RITA on H460 cells PMC4910870
HCT116 0.25 μM Evaluate the antiproliferative activity of RITA on HCT116 cells PMC4910870

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
SCID mice HCT116 and HCT116 TP53-/- xenograft tumors Intra-tumoral injection 1 mg/kg Not specified In p53-positive HCT116 xenograft tumors, RITA treatment led to a decrease in HdmX protein levels, while no such effect was observed in p53-null HCT116 TP53-/- xenograft tumors. PMC3190111
BALB/c nude mice HCT116 ARID1A+/+ and ARID1A−/− xenograft model Intravenous injection 10 mg/kg Daily for 17 days Evaluate the therapeutic effect of RITA in ARID1A-deficient tumors PMC11136964
BALB/c mice HCT116 cell-derived tumor xenografts Intraperitoneal injection 10 mg/kg Single dose, analyzed after 24 hours RITA induced p53 and γH2AX phosphorylation in vivo and reduced HIF-1α and VEGF expression. PMC2663300
Mice Pin1 knockout mice Intraperitoneal injection 20 mg/kg Single dose, sacrificed after 3 hours To evaluate the effect of Pin1 on doxorubicin-induced mitochondrial accumulation of p53, results showed absence of p53 mitochondrial accumulation in Pin1-deficient cardiac tissues. PMC3554345
BALB/c nude mice HN4-cisR xenograft model Intraperitoneal injection RITA 10 mg/kg, 3-MA 25 mg/kg Once daily for 35 days RITA plus 3-MA significantly inhibited HN4-cisR tumor growth, increasing oxidative stress and DNA damage PMC5925444

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.42mL

0.68mL

0.34mL

17.10mL

3.42mL

1.71mL

34.20mL

6.84mL

3.42mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories